A Review on Enzymes As Diagnostic Reagents and Therapeutic Agents
Total Page:16
File Type:pdf, Size:1020Kb
Volume 5, Issue 12, December – 2020 International Journal of Innovative Science and Research Technology ISSN No:-2456-2165 A Review on Enzymes as Diagnostic Reagents and Therapeutic Agents Afreen H1, Kiran Manoj2, Rajeev Nateshkumar3 Anna University Chennai1, Central University of Rajasthan2, University of Mumbai3 Abstracts:- The present review is based on papers There originates a confusion in interpreting the results as published between 1972 and 2020 and gives Comparative there are several modes/units to express cholinesterase activity information about the most common enzymes as and thus a careful standardization of the different units needs Diagnostic reagents and their clinical applications in to be done. disorders. Activities of following enzymes: Acid Phosphatase, Alanine Aminotransferase, Alkaline The main applications of these methods could be helpful Phosphatase, Cholinesterase, Creatinine Kinase, Gamma in identifying the serum cholinesterase levels which may be an Glutamyl Transferase, Lactate Dehydrogenase, Renin, indication of some disease or disorder, especially of the Urokinase. nervous system as acetylcholine is present in the synaptic junctions of the neurons and functions as a chemical Keywords:- Enzymes, Renin, Therapeutic applications of messenger. This could further help to develop commercial enzymes, Diagnostic Reagents, Phosphatase. reagent kits or point of care devices for the accurate and early diagnosis of the said disorders. I. INTRODUCTION AND DISCUSSION Activity of phenyl carbamate analogues of Rivastigmine as Cholinesterase a novel therapeutic agent for the treatment of Alzheimer’s disease. Quantitative analysis and estimation of cholinesterase for There have been several strategies that have been diagnostic purposes for laboratory and commercial use. followed for the treatment of Alzheimer’s of which the use of The different quantification methods being employed for cholinesterase inhibitors is the most studied and most used the estimation of cholinesterase have been discussed briefly. form of palliative treatment. Due to many advantageous There is an increasing need for reliable tests for assessing the features, donepezil has been the most used drug. cholinesterase status of patients. This will be useful in identifying the poisonings caused by cholinesterase inhibitors In this paper, the studies have been centred around such as the organophosphate or carbamate insecticides. rivastigmine which is the next best treatment and the pros and cons have been elaborated. Rivastigmine shows an interesting The basic hydrolysis of acetylcholine, a selectivity in the brain regions that are most affected by neurotransmitter, yields choline and acetic acid, of which the neuronal degradation. Some limitations in the usage of this acetic acid produced needs to be quantified to measure the drug is the short half-life period, difficulty in intake and the cholinesterase activity in a specimen. The different methods high cost associated with the synthesis of its intermediate – N- that have been studied and utilised for clinical and commercial ethyl-N-methyl carbamoyl chloride. purposes are briefly stated as follows: electrometric, titrimetric, manometric and colorimetric methods. The main Some recent studies have been conducted on dimethyl, criteria for the assays were sensitivity and reproducibility. diethyl and n-hexyl carbamates related to rivastigmine to try and overcome these limitations. The synthesised compounds The titrimetric method utilised the pH-stat where have been evaluated for the acetylcholinesterase and electronic means are used to maintain a constant pH. This butyrylcholinesterase in different cerebral regions such as the method is very sensitive and the most reproducible but the cortex, striatum and hippocampus. The LD50, IC50 and ED50 only limitation was that the cost of the equipment is high. The values have been estimated for the several compounds. manometric method is also sensitive but it is more time consuming in comparison with the other methods. Graded Thus, the therapeutic effects of the carbamate derivatives colour changes are observed under controlled reaction of Rivastigmine have been analysed for their efficacy and conditions in the colorimetric method and this method could toxicity. Conformational analysis has also been performed to be employed in places with no access to laboratories as well. determine the minimal energy conformations that is best suited for our needs. The different compounds have been compared and analysed to suggest which of them would be IJISRT20DEC024 www.ijisrt.com 27 Volume 5, Issue 12, December – 2020 International Journal of Innovative Science and Research Technology ISSN No:-2456-2165 useful as a potential drug candidate. The further clinical trials Donepezil, is a non-competitive, reversible have not been done on this drug and there is still much more cholinesterase inhibitor with high selectivity used to reduce information to be understood before it could be decisively neuronal degradation. The limitation is that it is not able to considered as a potential candidate. penetrate the blood brain barrier (BBB), thereby exhibiting a limited potential in treatment of AD. Clinical evidence-based studies recommendations for the use of cholinesterase inhibitors – A Literature Review The different hypotheses regarding the pathogenesis of Cholinesterase inhibitors have been a standard therapy Alzheimer’s are discussed here including the cholinergic for patients with Alzheimer’s disease. Tacrine was the first hypothesis, amyloid hypothesis, oxidative stress hypothesis used compound for the treatment of AD, but it was later and bio metal hypothesis. It has been discussed how different replaced by donepezil due to the substantial hepatotoxicity it structural/biochemical modifications have been done on the caused. Donepezil (Aricept), rivastigmine (Exelon) and donepezil and its analogues and how effective they are in the galantamine (Reminyl) have been considered for this study. treatment of Alzheimer’s. The papers that have been collected for this review were With the help of molecular docking, several different grouped into 3 classes; Class I that included randomised, compounds have been produced by making structural controlled, clinical trials and overviews (meta-analysis); Class modifications to the enzyme, and this could serve as potential II that included well designed observational studies with drug targets. This is the main idea behind the development of concurrent controls and Class III that included expert multi-target directed ligands (MTDLs). The main properties opinions, case series, case reports and historical controls. that are being focussed are the BBB permeation, additional antioxidant property, additional inhibition, ROS scavenge The 3 cholinesterase inhibitors that have been considered ability, improving memory performance, etc. in this study have different half-life and metabolisms. Donepezil has a longer half-life in comparison with the other Of the available drugs, almost all of them are only used two drugs. Donepezil and galantamine are metabolised with to relieve the symptoms or slow down the progression of the the help of cytochrome p450 enzymes while rivastigmine is disease. Hence, it is the need of the hour to develop hybrids of hydrolysed to a phenolic by product and excreted through the available drugs with a MTDL property wherein two or urine. Donepezil has the highest protein binding. Galantamine more distinct pharmacophores that recognise diverse targets and rivastigmine have delayed absorption caused by intake of that may be closely related to AD are combined to yield a drug food. with multiple benefits and minimal side effects. If more detailed analysis is done, some of these compounds could be MEDLINE and PUBMED are scientific journals that shortlisted to be potential drug targets for the treatment of have been used as a source for the papers that have been Alzheimer’s. published and a comparison in action between the different drugs employed and a spectrum of varying responses have Creatine Kinase been identified from patients and the outcomes have been distinguished as primary and secondary outcomes. Serum creatine kinase as a biomarker in systemic lupus erythematosus. The overall efficacy of these cholinesterase inhibitors This paper summarises a case report of a patient has been thoroughly summarised based on a comparative prognosis and treatment administered for systemic lupus study of all the literature that has been published. This helps erythematosus (SLE). The different therapies that have been us understand the precise action of the drug, the possible side administered and the side effects caused have been studied. A effects and also if it gives rise to any comorbidities depending better understanding of the primary SLE-induced infection of on the patient’s medical history. However, the clinical issues the musculoskeletal system and the drug-induced side effects of when to stop the treatment have not been studied or is important for appropriate treatment of SLE patients. reported. There is an absence of direct comparative trials. The patient had initially presented with arthralgia, Multi-target directed ligands against cholinesterase for arthritis, myalgia, pleuritis, and Raynaud’s phenomenon and Alzheimer’s treatment based on modifications on was diagnosed as having a mixed connective tissue disease. Donepezil Glucocorticosteriods and chloroquine were provided as a Despite the detailed studies on Alzheimer’s,